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Abstract
Background: The etiology of myelodysplastic syndromes (MDS) is largely unknown. Exposure to cigarette smoke (CS) is
reported to be associated with MDS risk. There is inconsistent evidence that deficiency of NAD(P)H-quinone: oxidoreductase
1 (NQO1) increases the risk of MDS. Earlier we had shown that CS induces toxicity only in marginal vitamin C-deficient
guinea pigs but not in vitamin C-sufficient ones. We therefore considered that NQO1 deficiency along with marginal vitamin
C deficiency might produce MDS in CS-exposed guinea pigs.
Methodology and Principal Findings: Here we show that CS exposure for 21 days produces MDS in guinea pigs having
deficiency of NQO1 (fed 3 mg dicoumarol/day) conjoint with marginal vitamin C deficiency (fed 0.5 mg vitamin C/day). As
evidenced by morphology, histology and cytogenetics, MDS produced in the guinea pigs falls in the category of refractory
cytopenia with unilineage dysplasia (RCUD): refractory anemia; refractory thrombocytopenia that is associated with ring
sideroblasts, micromegakaryocytes, myeloid hyperplasia and aneuploidy. MDS is accompanied by increased CD34(+) cells
and oxidative stress as shown by the formation of protein carbonyls and 8-oxodeoxyguanosine. Apoptosis precedes MDS
but disappears later with marked decrease in the p53 protein. MDS produced in the guinea pigs are irreversible. MDS and all
the aforesaid pathophysiological events do not occur in vitamin C-sufficient guinea pigs. However, after the onset of MDS
vitamin C becomes ineffective.
Conclusions and Significance: CS exposure causes MDS in guinea pigs having deficiency of NQO1 conjoint with marginal
vitamin C deficiency. The syndromes are not produced in singular deficiency of NQO1 or marginal vitamin C deficiency. Our
results suggest that human smokers having NQO1 deficiency combined with marginal vitamin C deficiency are likely to be
at high risk for developing MDS and that intake of a moderately large dose of vitamin C would prevent MDS.
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Introduction
Myelodysplastic syndromes (MDS) are a heterogeneous group
of clonal hematological disease characterized by bone marrow
hypercellularity, dysplasia, various degrees of cytopenia and a risk
of progression to acute myeloid leukemia [1,2]. MDS are divided
into two groups, de novo and therapy related. Features of therapy
related MDS include a myelodysplastic phase after the use of
cytotoxic chemicals and/or radiotherapy for a malignant disease
[2,3]. De novo MDS is a disease of elderly people [4]. MDS patients
have a poor survival. The genetic factor(s) and the environmental
risk factor(s) leading to the increased susceptibility to MDS are
poorly understood. Also one area that has not been explored is the
influence of nutrition in MDS development [2].
Exposure to cigarette smoke (CS) and benzene are reported to
be associated with MDS risk [5–10]. Risk from CS seems to be
related to intensity and duration of smoking [2,7,11,12]. In the
case of benzene-induced MDS, the risk factor may be attributed to
its metabolite p-benzoquinone (p-BQ), which targets to the bone
marrow [5,6]. Like that observed with benzene, the risk factor
derived from CS for causing MDS may also be attributed to p-BQ.
p-BQ is not present in CS, but it is apparently produced in vivo
from p-benzosemiquinone (p-BSQ) of CS [13–15] by dispropor-
tionation [16] and oxidation by transition metal containing
proteins [14]. p-BSQ is present in substantial amounts (100–
200 mg/cigarette) in smoke from all commercial cigarettes
examined as well as Kentucky research cigarettes [14,17]. p-BQ
is detoxified and thereby inactivated by NAD(P)H: quinone
oxidoreductase 1 (NQO1), an enzyme ubiquitously present in all
tissues, including the bone marrow [6,18–20]. Normal NQO1
activity would protect individuals from p-BQ toxicity of the
hematopoietic system. It is conceivable that NQO1 deficiency
would increase one’s risk of bone marrow toxicity. NQO1
deficiency is caused by polymorphism in NQO1
*2, a single
nucleotide change at position 609 of the NQO1 cDNA coding for
a proline to serine change at position 187 in the amino acid
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individuals with NQO1 deficiency may be at increased risk for the
development of various forms of blood dyscrasia, including MDS
and leukemia [6,18,21–23]. However, the results in different
populations have not been consistent. A few reports show that lack
of NQO1 activity does not correlate with increased risk of
malignancy [24–26]. It is known that not all smokers have the risk
for degenerative diseases. Only 15 per cent of the smokers are
afflicted with diseases [27]. We considered that along with NQO1
deficiency, some other risk factor(s) might be involved in causing
MDS.
Besides enzymatic detoxication by NQO1, p-BQ is strongly
inactivated by vitamin C. Earlier we had reported that CS
produces toxicity and tissue damage only in marginal vitamin C-
deficient guinea pigs, but not in vitamin C-sufficient ones [14,
28–29]. We had previously indicated that a moderately large dose
of vitamin C prevents CS-induced toxicity and tissue damage by
reducing and thereby inactivating p-BQ [14]. We therefore
considered that in addition to NQO1 deficiency, the nutritional
status of vitamin C might be a critical determining factor for
causing CS-induced MDS.
Understanding the relationship among CS exposure, NQO1
deficiency and marginal vitamin C deficiency in population-based
studies is problematic. We have addressed this relationship using a
guinea pig model. Here we show that CS exposure produces MDS
only when the guinea pigs have deficiency of NQO1 conjoint with
marginal vitamin C deficiency. MDS are not produced in singular
deficiency of either NQO1 or marginal vitamin C deficiency. Also,
MDS do not occur in vitamin C-sufficient guinea pigs.
Results
Vitamin C status in plasma and bone marrow
We have produced marginal vitamin C deficiency in guinea pigs
(350–450 g body weight) by feeding them 0.5 mg vitamin C/day.
Vitamin C sufficient guinea pigs were fed 15 mg vitamin C/day.
The minimum dose of vitamin C needed to maintain the guinea
pigs without onset of scurvy is 0.15 mg/100 g body weight [30].
At the dosage of 0.5 mg/day/350–450 g body weight, no scurvy
symptom appeared up to a period of 8 weeks. Table 1 shows that
after feeding vitamin C-deficient diet at a dose of 0.5 mg/day for
21days, the vitamin C levels are very low in the plasma and bone
marrow of guinea pigs that are not detectable after exposure to
CS. This is apparently because CS consumes vitamin C [29].
When the guinea pigs were fed 15 mg vitamin C/day, the vitamin
C contents of plasma and bone marrow were adequate.
Bone marrow NQO1 activity
NQO1 deficiency was produced by feeding an aqueous
suspension of dicoumarol [3,39-methylene-bis(4-hydroxycoumar-
ine), Sigma, USA], an inhibitor of NQO1 [31]. Figure 1A shows
that feeding dicoumarol (DC) at a dose of 3 mg/day for 21 days
produces about 90% inhibition of NQO1 activity in the bone
marrow of guinea pigs. The decrease in the NQO1 activity took
place gradually up to 21 days of the experimental period
(Figure 1B). Western blot analysis shows that there is no
significant change in the NQO1 gene expression at the protein
level (Figure S1).
Occurrence of MDS in guinea pigs as evidenced by
morphology, histology and cytogenetic studies
One important method of diagnosis of MDS relies on
morphologic assessments based on World Health Organization
(WHO) classification [32]. Here we have diagnosed MDS in
guinea pigs on the basis of bone marrow cell morphology,
histology and cytogenetic examinations. The guinea pigs were
divided into 8 groups (6 animals/group): (i) 0.5 mg vitamin C and
exposed to air (sham controls), (ii) 0.5 mg vitamin C and exposed
to CS, (iii) 0.5 mg vitamin C fed DC and exposed to air, (iv)
0.5 mg vitamin C fed DC and exposed to CS, (v) 15 mg vitamin C
and exposed to air, (vi) 15 mg vitamin C and exposed to CS, (vii)
15 mg vitamin C fed DC and exposed to air, and (viii) 15 mg
vitamin C fed DC and exposed to CS. All the guinea pigs of
groups (i–iii) and (v–viii) were fed with respect to the average food
consumption of the guinea pigs of group (iv). After exposure to CS
for 21 days, MDS were produced only in the guinea pigs having
deficiency of NQO1 conjoint with marginal vitamin C deficiency.
Figure 2A, V and IX show that in comparison to normal
segmented neutrophils (Figure 2AI), there are hyper segmented
neutrophils (7 lobes) in the blood film of MDS guinea pigs. These
observations indicate dysgranulopoiesis, as reported by others
[33]. Figure 2AXIII depicts poorly functioning large platelets in
the MDS guinea pigs, as compared to the platelets observed in the
blood film of guinea pigs fed 0.5 mg vitamin C/day and exposed
to air (Figure 2AI). In contrast to all other experimental groups
there was significant decrease in the number of platelets in the
MDS guinea pigs (Table S1). All these various changes were
observed in the MDS guinea pigs, but not in any of the guinea pigs
other than MDS, including vitamin C-sufficient guinea pigs fed
15 mg vitamin C/day (Figure 2A XVII).
MDS are usually present with myeloid hyperplasia in the bone
marrow [34]. However, some types have erythroid predominance
such as RA and RARS (32). We also observed that the myeloid to
nonmyeloid ratio increased 4 fold (p,0.05) in the bone marrow of
MDS guinea pigs compared to the guinea pigs of all others groups.
The ratio increased gradually up to 21 days of the experimental
period (Table S2 and Figure S2A). However the guinea pigs
exposed to cigarette smoke only without the addition of vitamin C
show no myeloid hyperplasia (Table S2 and Figure S2A). There
was no change in the WBC count in the blood, but RBC and
hemoglobin were significantly decreased (p,0.05, n=6) in the
MDS guinea pigs (Table S1). Morphologically, dysplasia was seen
in all the lineages with predominance in the erythroid and
granuloid lineages. Quantitation of dysplasia indicate: dysplasia in
15% of the cells in the erythroid lineages, 9.5% in the granuloid
lineage and 8% in the megakaryocytic lineage. Figure 2AII shows
Table 1. Vitamin C levels in the plasma and bone marrow of
guinea pigs fed 0.5 mg/day and 15 mg/day vitamin C for 21
days and exposed to air or CS.
Vitamin C level
Plasma (mg/100 ml) Bone marrow (mg/10
8 cells)
Vitamin C supplementation/day
Group 0.5 mg 15 mg 0.5 mg 15 mg
Air 0.1260.01* 0.6760.04 0.1860.02 5.1760.29
DC 0.1460.01 0.8960.02 0.1360.01 2.2760.06
CS ND 0.4460.12 ND 2.6560.20
DC+CS ND 1.2760.20 ND 2.7560.10
Dietary supplementation of vitamin C 0.5/15 mg/day) was initiated after
deprivation of the vitamin for 7 days. The vitamin C contents of plasma and
bone marrow were estimated on day 21
st by HPLC as described under Materials
and Methods. ND means not detectable. * Data represent mean 6S.D. (n=4).
doi:10.1371/journal.pone.0020590.t001
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primitive nuclear chromatin pattern in guinea pigs fed 0.5 mg
vitamin C/day and exposed to air. In contrast to this, Figure 2AVI
depicts marked hyper- cellular vacuolation with some megalo-
blastoid changes and Figure 2AX shows ring sideroblasts. Many
blue siderotic granules were surrounding the nucleus, as evidence
of dyserythropoiesis found in MDS guinea pigs [33]. It has been
reported that pathologic iron accumulation occurs in the
erythroblasts as evidence of dyserythropoiesis in MDS [35,36].
Figure 2AXIV depicts blue spots (Perls’ stain) in the bone marrow
of MDS guinea pigs that represent iron accumulation as evidence
of dyserythropoiesis. The dyserythropoiesis was prevented in CS-
exposed NQO1-deficient guinea pigs by feeding the animals
15 mg vitamin C/day (Figure 2AXVIII).
In granuloid lineage, Figure 2AIII depicts normal neutro-
philic myelocyte with eccentric nucleus and faint cytoplasm.
Compared to this, bone marrow of MDS guinea pig shows
dysplastic myelocyte indicating abnormal separation of nuclear
lobes (Figure 2AVII) and atypical mononuclear cells with
altered nuclear and cytoplasm ratio (Figure 2AXI). This suggests
dysgranulopoiesis in MDS. Dysgranulopoiesis did not occur in
guinea pigs fed 15 mg vitamin C/day (Figure 2AXIX).
Figure 2AXV depicts myeloblast, the first recognizable cell of
the granuloid series. The percent of myeloblast increased
considerably in the MDS guinea pigs. In the guinea pigs fed
0.5 mg vitamin C and exposed to air, the myeloblast count has
been found to be 1.98%60.43 (p,0.05, n=6), whereas that in
the MDS guinea pigs is 4.88%60.63 (p,0.05, n=6). Bone
marrow hematopoietic progenitor cells are a heterogeneous
population with varying degree of maturation in several cell
lineages. It is reported that CD 34(+)c e l lp o p u l a t i o ni si n c r e a s e d
in MDS [36,37]. Using flow cytometry analyses, here we show
that the percentage of CD 34(+)c e l l si nt h eb o n em a r r o wo f
MDS guinea pigs has increased significantly (p,0.05, n=6)
about 10% over that observed in the bone marrow of guinea
pigs fed 0.5 mg of vitamin C and exposed to air. No increase in
the CD 34(+) cells was observed in other experimental groups
(Figure 2B and C).
Also, compared to the all others groups the number of
megakaryocytes increased significantly (p,0.05, n=6) in the
MDS guinea pigs. However, the platelet count decreased (p,0.05,
n=6) (Table S1). This indicates occurrence of micromegakar-
yocytes (Figure 2A, VIII, XII), which are seen in MDS animal and
sterile dysplastic megakaryocytes (Figure 2A XVI) that evidences
dysmegakaryopoiesis as reported by others [33]. Figure 2A, IV
and XX show normal megakaryocytes.
Previous study had demonstrated that hypercellularity in the
bone marrow is a characteristic feature of MDS [38]. Using
hematoxylin and eosin (H&E) staining here we show that
compared to that observed in guinea pigs of other experimental
groups, including those fed 15 mg vitamin C/day, there is
significant (p,0.05, n=6) increase of bone marrow cellularity in
the MDS guinea pigs (Figure S2B II). However, there was no
increase in bone marrow cellularity in the guinea pigs exposed to
cigarette smoke only without addition of vitamin C (Figure S2B
IV). The quantitation of cellularity was made by numerical
counting using Dewinter Biowizard 4.1 software.
Numerical chromosomal aberrations, aneuploidy, are common
in cancer including hematopoietic tumor cells [39]. We have
observed aneuploidy in the MDS guinea pigs (Figure 2CII). The
number of chromosomes in normal guinea pigs is 62, karyotype
60+XY [40]. In MDS guinea pigs, the number varied from 116 to
128. A critical analyses of 100 metaphases revealed that 70%
metaphases represented normal karyotype, whereas 30% meta-
phases represented aberrations in MDS guinea pigs. No such
aberration occurred in CS-exposed NQO1–deficient guinea pigs
fed 15 mg vitamin C/day (Figure 2CIII).
All the aforesaid results indicate that the MDS occur only in CS-
exposed guinea pigs having deficiency of NQO1 conjoint with
marginal vitamin C deficiency. Such pathophysiological events did
not occur in any of the experimental groups other than MDS.
Nevertheless, as mentioned before supplementation of a moderately
high dose of vitamin C (15 mg/day) prevented the myelodysplastic
changes in CS-exposed NQO1-deficient guinea pigs.
The aforesaid results have been presented using Kentucky
research cigarettes 3R4F. In separate experiments, using a
commercial cigarette (Wills Navy Cut, ITC, India), similar MDS
was diagnosed on the basis of morphology, histology and
cytogenetics (data not shown). This was done to show that
Kentucky research cigarette was not specific.
Figure 1. NQO1 Activity of bone marrow cells of guinea pigs fed 0.5 mg or 15 mg vit C/day. (Panel A) AIR, exposed to air; DC, fed 3 mg
DC/day; CS, exposed to CS; DC+CS, fed 3 mg DC/day and exposed to CS. * indicates significant difference (p,0.05) with respect to air exposed guinea
pigs.(Panel B) NQO1 activity at different time periods of DC+CS group. * indicates significant difference (p,0.05) with respect to 0 day. Bars over the
respective columns represent means 6 SD (n=6), Vit C means vitamin C.
doi:10.1371/journal.pone.0020590.g001
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20590Figure 2. Identification of MDS in guinea pigs by blood and bone marrow cell morphology, measurement of CD34(+) cells and
cytogenetic studies. (Panel A) Differential staining showing some typical changes in blood and bone marrow cell morphology of MDS guinea pigs
and its prevention by feeding the animals 15 mg vitamin C/day. A, I–IV, represent sham controls (fed 0.5 mg vitamin C/day and exposed to air); A,
V–XVI, represent MDS guinea pigs (CS-exposed fed DC and 0.5 mg vitamin C/day); A, XVII–XX, represent CS-exposed guinea pigs fed DC and
15 mg vitamin C/day. Blood smear - Leishman stain; bone marrow aspirate - Wright Geimsa stain, except Perls’ stain in X and XIV; (magnification
4006, except I, V, VI, IX, XIII, XVII; 10006magnification). R indicates dysplastic cells. Vit C means vitamin C. (Panel B) Measurement of CD34(+) cells in
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It is reported that apoptosis is an early event in MDS and
ineffective hemaptopoiesis found in MDS is caused by an
increased incidence of apoptosis in bone marrow cells [41]. Here
we show that MDS is preceded by apoptosis of the bone marrow
cells. Apoptosis has been evidenced by TUNEL assay, flow
cytometry analysis using Annexin V/PI staining, phosphorylation
of p53, activation of caspase 3 and increase in the bax/Bcl-2 ratio
as well as up regulation of TNF-a and cleavage of caspase 8.
Figure 3, A and B show that in the guinea pigs fed 0.5 mg
vitamin C and 3 mg DC/day, there is progressive increase in the
number of TUNEL positive cells in the bone marrow after
exposure to CS for 7 and 14 days. However, after continuation of
CS exposure for 21 days, the TUNEL positive cells have
disappeared, which is accompanied by occurrence of MDS. The
TUNEL positive cells are also absent when the DC-treated CS-
exposed guinea pigs are fed 15 mg vitamin C/day. Since 15 mg
vitamin C prevents MDS (Figure 2), the results would indicate that
a moderately high dose of vitamin C prevents apoptosis and MDS.
As observed by TUNEL assay, flow cytometry analysis shows
(Figure 3C) that in the DC-treated CS-exposed guinea pigs fed
0.5 mg vitamin C, the apoptotic population (Annexin V +/PI 2)i s
maximum (24.52%) on day 14 and absent on day 21 (0.12%). The
percentage of necrosis is negligible.
That MDS is preceded by apoptosis is also evidenced by an
increase in the p53 level in the bone marrow cells on day 14
(Figure 3D, row 4), which is accompanied by an increase in
phosphorylated p53 (Figure 3F, row 1). After exposure to CS, the
p53 levels were comparatively higher on days 14 and 21 than those
observed on days 0 and 7 (Figure 3D, row 3). However, after
treatment with DC along with CS, the p53 levels were high on
days 7 and 14 but very low on day 21 (Figure 3D, row 4), when
apoptosis was absent and MDS appeared. This is supported by the
observation that while p-p53 level was high on day 14 when
apoptosis was high, it was absent on day 21 (Figure 3F, row 1)
when apoptosis disappeared and MDS appeared. Apoptosis is
further supported by an increase in the levels of Bax (not Bcl-2),
caspase 3, cleaved caspase 3 on day 14 that decreased in the MDS
guinea pigs on day 21 (Figure 3F, rows 2, 3, 4 and 5, respectively).
It had been reported that in early MDS increased apoptosis is
partially due to up regulation of TNF-a and death receptors [36].
Here we show that the levels of TNF-a and its downstream
effector cleaved caspase 8 are markedly increased on day 14. TNF-
a decreased considerably and cleaved caspase 8 was practically
absent in the MDS guinea pigs on day 21 (Figure 3H, rows 1 and
3, respectively). Apoptosis was absent in all the experimental
groups other than MDS as well as in the guinea pigs fed 15 mg
vitamin C/day (Figure 3E and G).
Activation of epidermal growth factor receptor (EGFR) has
been implicated in the pathogenesis of a variety of malignancies
including leukemia. Reports also indicate that the Akt pathway is
critical for cell survival and proliferation in high-risk MDS
patients. We have also observed activation of EGFR, MAPK/
Ras pathway as well as Akt in MDS produced in the guinea pigs
(Figure S3).
p-BQ-protein adduct and oxidative stress in MDS
CS contains substantial amount of p-BSQ, [15,17] a major
long-lived radical. We had shown before that p-BSQ is oxidized to
p-BQ by transition metal containing proteins [14]. The amount of
p-BQ calculated to be formed in the lungs from the inhaled
cigarette smoke is 22.5 mg/day (Supporting Information Text S1).
Using antibody against p-BQ and immunoblotting, here we show
that bone marrow proteins of marginal vitamin C-deficient CS-
exposed guinea pigs contain p-BQ-protein adducts (Figure 4, A
and B). Also, incubation of bone marrow cells in vitro with p-BQ or
aqueous extract of cigarette smoke (AECS) produced p-BQ-
protein adducts (Figure 4C). This would indicate that probably
one mechanism of CS-induced MDS is p-BQ-induced modifica-
tion of bone marrow proteins. The formation of p-BQ-protein
adduct is prevented by vitamin C (15 mg/day) (Figure 4A). p-BQ
is also a redox cycling agent [42]. The reactive oxygen species
(ROS) generated by redox cycling lead to the formation of protein
carbonyls as well as 8-oxo-7, 8-dihydroguanosine (8-oxodG) that
are associated with carcinogenesis [42]. As depicted in Figure 4D,
bone marrow cells of DC-treated vitamin C-deficient guinea pig
show increase in ROS at day 14 of CS-exposure, which is
decreased after continuation of exposure for 21 days. The
oxidative stress is further demonstrated by measuring protein
carbonyl, an evidence of protein oxidation, (Figure 4E) and 8-
oxodG, an evidence of DNA oxidation (Figure 4, F and G). No
ROS was produced in the guinea pigs fed 15 mg vitamin C
(Figure 4D), indicating that moderately high dose of vitamin C
prevents CS-induced oxidative stress.
MDS produced in the guinea pigs are irreversible
It is known that MDS is an irreversible condition caused in
some cases by genotoxicity. Here we show that MDS produced in
the guinea pigs are irreversible, as evidenced by bone marrow cell
morphology and cytogenetic examination. Six guinea piga were
fed 0.5 mg vitamin C and 3 mg DC/animal/day and exposed to
CS. Another 6 guinea pigs were fed 0.5 mg vitamin C/animal/
day and exposed to air (sham controls). After exposure to CS for
21 days, 2 out of the 6 guinea pigs were sacrificed and MDS
diagnosed by morphology and cytogenetic examination described
before in the text. CS exposure was discontinued in the remaining
4 guinea pigs and they were fed 15 mg vitamin C/animal/day.
Supplementation of DC (3 mg/day) was continued for maintain-
ing NQO1 deficiency. After 6 days, there was drastic fall in the
food intake and loss of body weight. At that stage, the animals
were sacrificed and blood smear, bone marrow cell morphology,
CD34(+) cell count and cytogenetic examination were performed.
We have also measured NQO1 activity and the p53 status in the
bone marrow. Figure 5A a, b, c, d show normal morphology in
blood and bone marrow cells. In contrast to these, Figure 5A e and
f depict poor functioning large platelets and dyserythropoietic
changes in bone marrow cells. Figure 5A g and h show
micromegakaryocyte and ring sideroblast. The percentage of
CD34(+) cells in the bone marrow increased significantly (p,0.05,
n=4) about 22% over that observed in the sham controls
(Figure 5B). Here we have also observed anuploidy, the number
varied from 104 to 120 (Figure 5C). A critical analyses of 100
metaphases revealed that 62% metaphases represented normal
karyotype, (Figure 5C) whereas 38% metaphases represented
anuploidy (Figure 5C). All these aforesaid results indicate that the
animals had persistent changes confirming irreversibility of MDS
produced in the guinea pigs. Figure 5D shows 90% inhibition of
NQO1 activity in the bone marrow without any change in the
bone marrow by flow cytometry. (Panel C) Quantitative evaluation of CD34(+) cells; bars (means 6 SD, n=6) over the respective columns represent
CD34(+) cells, * significantly different (p,0.05) with respect to 1–7 samples. (Panel D) Geimsa-stained metaphase spread showing aneuploidy in II;
(magnification 10006).
doi:10.1371/journal.pone.0020590.g002
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However, the p53 level was markedly low in the MDS guinea pigs
fed 15 mg vit C (Figure 5E, row 2).
Discussion
MDS represents a malignant entity that shares many charac-
teristics with acute myeloid leukemia (AML). Approximately one-
third of patients ultimately progress to AML [43]. MDS is 3–4
times more prevalent than AML and follows a more indolent
course [43]. The etiology of MDS is yet to be known in most
patients. However, intrinsic defects in hematopoietic cells and
extrinsic factors affecting bone marrow microenvironment are
involved in the pathogenesis of this disorder. One such extrinsic
factor is cigarette smoke. In this paper we have shown that CS
exposure mimics MDS in guinea pigs having deficiency of NQO1
conjoint with marginal vitamin C deficiency. Singular deficiency
of NQO1 or marginal vitamin C deficiency does not produce CS-
induced MDS. We have used the guinea pig as a model animal
because, like human, it is incapable of synthesizing vitamin C and
is dependent on the dietary source of the vitamin [44,45]. Also, the
guinea pig has anatomical and CS-induced pathophysiological
similarities to humans [46].
According to the WHO classification, [32] the MDS produced
in the guinea pigs fall in the category of refractory cytopenia with
unilineage dysplasia (RCUD): refractory anemia (RA); refractory
thrombocytopenia (RT). This has been evidenced by blood
findings of bicytopenia but no blast. Bone marrow findings
indicate unilineage dysplasia in .10% of the cells in one myeloid
lineages (15% erythroid, 9.5% granuloid, 8% megakaryocytic
lineages) and ,5% blasts (4.88%60.63 SD). Also, less than 15%
erythroid precursors are ring sideroblasts (6.0%). Perls’ stain
showed blue spots in marrow cells indicating iron accumulation.
MDS is also accompanied by micromegakaryocyte. Because three
lineages are affected, the disorders probably occurred at the
pluripotent stem cells. The abnormalities in hematopoiesis are
accompanied by an increase in hematopoietic precursor cells
(CD34+). We have also observed anueploidy in MDS guinea pigs,
indicating genomic instability. The MDS produced in the guinea
pigs are irreversible as evidenced by bone marrow cell morphol-
ogy, CD34 (+) cell count and cytogenetic studies.
Until now the risk factor(s) in CS responsible for producing
MDS has remained unclear. CS contains about 4000 compounds
[47], including a number of carcinogens [48] and semiquinones
[14,15]. Among the carcinogens, the most extensively studied
compounds are benzo[a] pyrene (BP) and 4-(methylnitrosamino)-
1-(3-pyridil)-1-butanone (NNK) [49]. The concentrations of these
in smoke from one cigarette are very low: 20–40 ng (BP) and 80–
960 ng (NNK), respectively [48,49]. Moreover, the carcinogenic
effects of both these compounds are organospecific. They produce
only lung tumor at very high doses [48]. We consider that the
apparent risk factor derived from CS for producing MDS is p-BQ.
CS does not contain p-BQ. p-BQ is produced from p-BSQ, which
is present in CS in substantial amounts depending on the brand of
the cigarette (100–200 mg/cigarette) [14,15,17]. p-BSQ is con-
verted to p-BQ by disproportionation: 2p-BQRp-BQ+Hydroqui-
none [16] as well as oxidation by transition metal (M) containing
proteins: p-BSQ+M
ox2ProteinRp-BQ+M
red2Protein [14]. p-
BQ derived from p-BSQ of CS gets into the bloodstream and
goes to the bone marrow, the target organ [5,6], where it interacts
with e-amino groups of lysine residues of proteins forming covalent
adducts [14,50]. Using antibody to p-BQ and western blot, here
we have demonstrated formation of p-BQ-protein adducts in the
bone marrow cells of CS-exposed guinea pigs. However, how p-
BQ causes MDS is not clear. It has been proposed for benzene-
induced leukemia that p-BQ derived from benzene causes damage
to tubulin, histone proteins, topoisomerase II leading to DNA
strand break, mitotic recombination and aneuploidy in stem cells
or early progenitor cells leading to leukemia [5].
p-BQ is also a redox cycling agent [42] that generates ROS
leading to the formation of protein carbonyl as well as 8-oxodG.
Elevated levels of 8-oxodG were found in a significant proportion
of MDS patients, indicating increased oxidative DNA damage or
defective handling of oxidative load [51]. In recent years the
biomarker 8-oxodG has become pivotal for measuring the effect of
endogenous oxidative damage to DNA and as a factor influencing
the initiation and promotion of carcinogenesis [52,53]. 8-oxodG is
a potent mutagen. Once incorporated into DNA, it codes for error
prone DNA synthesis [54]. We have documented the formation of
ROS, protein carbonyl as well as 8-oxodG in the bone marrow
cells of MDS guinea pigs.
We have shown that CS-induced MDS is produced only when
the guinea pigs have NQO1 deficiency conjoint with marginal
vitamin C deficiency. The function of vitamin C (E9u=+0.08 V) is
to reduce p-BQ (E9u=+0.71V) to the less toxic HQ, which is
excreted as sulfate and glucuronide. Although a function of NQO1
is also to reduce p-BQ, [6,18–20] we consider that NQO1 has
some other function than only to reduce and inactivate p-BQ. One
prominent function of NQO1 is to regulate the stability of p53.
NQO1 binds with p53 and stabilizes it [55]. We have produced
NQO1 deficiency in the guinea pigs by feeding them DC, a potent
inhibitor of NQO1 [55,56] The crystal structure of human NQO1
in complex with DC determined at 2.75 A ˚ resolution shows that
DC competes with NAD(P)H for binding to NQO1 and thereby
inhibits NQO1 activity [57]. The NQO1-dicoumarol complex
disrupts NQO1-p53 binding and induces ubiquitin-independent
proteasomal degradation of p53 [58]. However, here we show that
although there is some decrease in the p53 protein after treatment
with DC (Figure 3D, row 2), there is a marked decrease of p53
after treatment with DC along with CS. (Figure 3D, row 4). The
possibility that p-BQ derived from CS formed adduct with p53
resulting in proteolytic degradation of the protein [14] is
eliminated, because there is no loss of p53 after CS treatment
(Figure 3D, row 3). The mechanism of marked decrease of p53
accompanied by disappearance of apoptosis and appearance of
MDS is not clear at present. p53 is a tumor suppressor protein that
can induce apoptosis and cell cycle arrest and thereby prevent
accumulation of DNA-damaged cells that could lead to the
development of cancer [31,59]. We consider that loss of p53 may
be associated with the development of MDS. Cells lacking p53 are
Figure 3. Assessment of apoptosis by TUNEL assay, flow cytometry and cell signaling in bone marrow cells of guinea pigs. (Panel A)
TUNEL assay of bone marrow cells. The rows were stained with fluorescein labeled dUTP and 4, 6-diamidino-2-phenylindole (DAPI), respectively;
green fluorescence indicates TUNEL positive cells (magnification 2006). (Panel B) Quantitative evaluation of TUNEL positive cells; bars (means 6 SD,
n=6) over the respective columns represent TUNEL positive cells, * significantly different (p,0.05) with respect to 0 day, ** significantly different
(p,0.05) from 14 days treatment. (Panel C) Flow cytometry analyses of bone marrow cells using Annexin V-FITC fluorescence (Y-axis) vs PI (X-axis);
quadrants: lower left, viable cells; upper left, apoptotic cells; upper right, late apoptotic and lower right, necrotic cells. (Panel D) p53 status in the
bone marrow cells at different time. (Panel E) and (Panel F) Immunoblots of p-p53 (phospho-p53), Bax, Bcl-2, caspase 3 (C3), cleaved caspase 3 (CC3).
(Panel G) and (Panel H) Immunoblots of TNF-a, caspase 8 (C8) and cleaved caspase 8 (CC8). Vit C means vitamin C.
doi:10.1371/journal.pone.0020590.g003
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aneuploid [59]. So, one of the causes of aneuploidy observed in
MDS guinea pigs may be decrease in the p53 protein level.
Vitamin C has a long and controversial history in the
prevention and treatment of cancer. In an experiment on guinea
pigs, it was shown that methylcholanthrene induced tumors sooner
in the animals deficient in vitamin C as compared to those fed
adequate amount of vitamin C [60]. Several epidemiological
studies have pointed to the importance of dietary and Supporting
vitamin C in the prevention of various types of cancer, including
leukemia [61,62]. In leukemic patients, the plasma levels of
vitamin C were practically undetectable [63]. A number of recent
papers show that pharmacological doses of vitamin C decreases
growth and weight of human, rat and murine tumor xenografts in
athmyc, nude mice [64]. Results indicate that high doses of
vitamin C are safe and well tolerated in different patients [64].
We have observed that MDS is preceded by apoptosis of
marrow cells. Apoptosis is a well recognized phenomenon in
Figure 4. Identification of p-BQ-protein adducts and detection of oxidative stress in bone marrow cells of guinea pigs. (Panel A) p-BQ
protein adducts in the bone marrow cells of CS-exposed guinea pigs on day 21 in vivo. (Panel B) p-BQ protein adducts in CS-exposed guinea pigs at
different time period in vivo. (Panel C) p-BQ protein adducts formed in marrow cells in vitro after incubation with p-BQ and AECS (aqueous extract of
cigarette smoke), respectively; M, marker (cropped). (Panel D) ROS production in MDS guinea pigs at different time periods, as evidenced by flow
cytometry. The X-axis represents the intensity of dichlorodihydrofluorescein diacetate (H2DCFDA). (Panel E) Protein oxidation as evidenced by oxyblot
indicating formation of protein carbonyl. (Panel F) DNA oxidation as evidenced by the formation of 8-oxodG; upper row: green fluorescence indicates
formation of 8-oxodG; lower row: stained with DAPI; (magnification 2006). (Panel G) Quantitative evaluation of 8-oxodG; * indicates significant
difference from 0 and 7 days. Vit C means vitamin C.
doi:10.1371/journal.pone.0020590.g004
Figure 5. MDS produced in the guinea pigs are irreversible. (Panel A) Differential staining showing persistent changes in blood and bone
marrow cell morphology of MDS guinea pigs followed by discontinuation of CS exposure and feeding 15 mg vitamin C/day. A, a–d, represent sham
controls (fed 0.5 mg vitamin C/day and exposed to air); A, e–h, represent MDS guinea pigs followed by discontinuation of CS exposure and feeding
15 mg vitamin C/day. Blood smear - Leishman stain; bone marrow aspirate - Wright Geimsa stain, except Perls’ stain in d and h; (magnification
4006). (Panel B) Measurement of CD34(+) cells in bone marrow by flow cytometry. (Panel C) Geimsa-stained metaphase spread showing aneuploidy
in MDS guinea pigs followed by discontinuation of CS exposure and feeding 15 mg vitamin C/day; (magnification 10006). (Panel D) NQO1 Activity of
bone marrow cells. Bars over the respective columns represent means 6 SD (n=4); * indicates significant difference (p,0.05, n=4) with respect to air
exposed guinea pigs. (Panel E) NQO1 and p53 status in the bone marrow cells.
doi:10.1371/journal.pone.0020590.g005
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is especially enhanced in early MDS and declined in late MDS
and absent in leukemia [66]. In MDS guinea pigs, we have
observed both intrinsic pathways of apoptosis involving Bax,
Bcl-2 and caspase 3 as well as extrinsic pathway involving TNF-
a and caspase 8. A higher expression of TNF-a has actually
been found in MDS that correlates with apoptosis [36]. Marked
apoptosis is observed on day 14 in the bone marrow cells of
CS-exposed guinea pigs having deficiency in NQO1 and
marginal vitamin C deficiency. Apoptosis disappears on day
21, which is accompanied by occurrence of MDS. Apparently
the cells that escape apoptosis survive and proliferate to
produce hypercellularity and MDS. In the MDS guinea pigs,
increased cellular proliferation has probably occurred via
activation of EGFR, Ras/MAPK pathway as well as Akt
(Supporting Results in Text S1). It is reported that CS-induced
persistent activation of EGFR, ERK1/2 and Akt results in cell
proliferation and transformation [67].
In conclusion, our results suggest that three factors combined
together lead to CS-induced MDS: exposure to CS, NQO1
deficiency and marginal vitamin C deficiency. MDS is not
produced in vitamin C-sufficient guinea pigs fed a moderately
high dose of vitamin C. However, after the onset of MDS vitamin
C becomes ineffective. Like that observed in humans, MDS
produced in the guinea pigs are irreversible. If the results obtained
with guinea pigs are applicable to human, smokers having NQO1
deficiency conjoint with marginal vitamin C deficiency would be
at high risk for developing MDS. Nevertheless, intake of a
moderately high dose of vitamin C should prevent occurrence of
MDS in smokers.
Materials and Methods
Animals
Male short hair guinea pigs weighing 350–450 g were divided
into weight-matched groups and fed vitamin C-free diet
(Supporting Information Text S1) for one week to minimize the
vitamin C level of tissues [28]. After 1 week, the guinea pigs were
fed either vitamin C-deficient (0.5 mg/day) or vitamin C-sufficient
diet (15 mg/day) [29].
Ethics Statement
All methods were approved by the Institutional Animal Ethics
Committee, Permit No. 797/CPCSEA, Department of Biochem-
istry, University of Calcutta. All efforts were made to minimize
suffering of the animals.
Exposure to cigarette smoke
The guinea pigs were subjected to cigarette smoke exposure
from 5 Kentucky Research cigarettes 3R4F (2 puffs per cigarette)/
animal/day (6 days/week) in a smoke chamber, as described
before [14], except that the time of exposure was 90 seconds
instead of 45 seconds (for details, see Supporting Information Text
S1). Pair-fed sham controls were subjected to air exposure instead
of CS under similar conditions. After the experimental period, the
animals were euthanized under deep anesthesia using i.p. injection
of ketamine hydrochloride (100 mg/kg body weight) and there-
after the respective tissues were excised.
Measurement of vitamin C
Vitamin C was measured by HPLC as described before [14],
except that 0.13 mM ß-mercaptoethanol was added to the plasma
and bone marrow lysate to prevent oxidation of vitamin C.
Bone marrow NQO1 activity and protein
Bone marrow was homogenized in a buffer containing 50 mM
Tris-HCl ph7.4, 250 mMsucrose, 1 mM EDTA [21] and cytosol
prepared by centrifuging at 19000 g for 15 minutes. The cytosolic
fraction (75 mg protein) was analyzed for NQO1 activity following
the decrease in NADH absorbance at 340 nm in a UV-2450 UV-
VIS spectrophotometer (Shimadzu) [31]. NQO1 protein was
measured by western blot followed by densitometry using antibody
against NQO1 (Santa Cruz biotechnology, Inc., California, USA)
as described elsewhere [21].
Cytochemistry
After surgically opening the femurs, bone marrow was aspirated
by suction and expelled in small fractions on a number of
microscopic slides and smears prepared. After air drying the
smears were stained separately with Wright-Giemsa (Sigma-
Aldrich, USA), Myeloperoxidase, Sudan Black, and Perls’ stain
(Merck, India) by standard procedures [68] and then examined
under bright field microscope (Dewinter) equipped with high
resolution digital Digieye 330/210 camera and Dewinter Biozard
4.1 software.
Histology of bone marrow
The bones were surgically removed, placed in 10% neutral
buffered formalin for 24 hours, decalcified in 7.5% formic acid for
72 hours and then processed routinely [21]. The tissues were
embedded in paraffin, subjected to microtomy at 5 mm and
prepared routinely for hematoxylin and eosin (H&E, Merck, India)
staining and analyzed under bright field microscope (Dewinter).
Measurement of CD34+ cells
Bone marrow cells were aspirated in phosphate buffered saline
(PBS), fixed in 2% paraformaldehyde, pH 7.4, followed by
permeabilization. Then blocking was done with 5% BSA in PBS
solution for 1 hour at room temperature. After two washes in PBS,
primary antibody against CD34 (Santa Cruz biotechnology, Inc.,
USA) was added and incubated over night at 4uC. The cells were
then washed and incubated with FITC conjugated anti mouse IgG
for 1 hour and analyzed by FACS (FACS Caliber, Becton
Dickinson, California, USA).
Evaluation of chromosomal aberration
One hour after i.p injection of colcemid (0.04%, 10 ml/kg
body weight), the bone marrow cells were aspirated in a
hypotonic solution (0.075 M KCl) and evaluated for chromo-
somal aberration [21].
Measurement of apoptosis
Apoptosis was measured by using the terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling assay (TUNEL) [14]
as well as by flow cytometry analysis (FACS) using Annexin V-
propidium iodide (PI), as described previously [17].
Immunoblot analyses
The bones of the experimental animals were cut, marrow
flushed out, homogenized in lysis buffer containing 50 mM Tris-
Cl (ph 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 1% NP-
40, 0.5% Trion X-100, protease inhibitor cocktail (Sigma, USA)
and phosphatase inhibitor cocktail 2 (Sigma, USA) [21] and then
centrifuged at 19000 g for 15 minutes. Bone marrow lysates
(75 mg protein) were separated on 10% SDS-PAGE, blotted on
PVDF membrane, and probed with respective antibodies against
p53, phospho-p53, Bax, Bcl-2, caspase 3, cleaved caspase 3,
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Technology, USA). For identification of p-BQ-protein adducts,
lysates were prepared from bone marrow cells of MDS guinea
pigs or bone marrow cells of sham control guinea pigs after
incubation with aqueous extract of CS (AECS) for two hours in
vitro, as described before [14,17]. Then the lysates were
immunoblotted using antibody (rabbit, polyclonal) against p-
BQ. The antibody to p-BQ, raised in rabbit after immunization
with p-BQ-bovine serum conjugant, was supplied by Abexome
Biosciences, Bangalore, India.
Measurement of ROS and oxidative damage
ROS was measured by flow cytometry (FACS Caliber, Becton
Dickinson, USA) using dichlorodihydrofluorescein diacetate
(H2DCFDA) as per manufacturer’s (Sigma, USA) instruction.
Data were acquired and analyzed using the CELLQuest
Programme. Protein oxidation was measured by the formation
of protein carbonyl using antibody to 2, 4-dinitropheny-hydrazine
(DNPH) as per Oxyblot
TM protein oxidation detection kit
(Intergen, NY) described previously [14]. 8-oxodG was detected
by immunofluorescence using antibody to 8-oxodG as per
manufacturer’s (Abcam, UK) instruction.
Statistical analyses
All values are expressed as mean 6 SD. Statistical significance
was carried out using a two factor ANOVA, with factors being CS
and DC/vitamin C, or one way ANOVA as needed. The p- values
were calculated using appropriate F-tests. Difference with p-
values,0.05 were considered significant.
Supporting Information
Figure S1 NQO1 expression in the bone marrow cells,
indicating that there is no significant change in NQO1
expression at the protein level. (Panel A) and (Panel B) Bone
marrow lysates were separated by 10% SDS PAGE and subjected
to immmunobloting using antibody against NQO1. Vit C means
vitamin C.
(TIF)
Figure S2 Differential staining of bone marrow cells
showing myeloid hyperplasia and hypercellularity in
MDS guinea pigs. (Panel A) Bone marrow aspirates showing
myeloid hyperplasia; magnification 2006. (Panel B) Bone marrow
histology showing hypercellularity; magnification 4006. Vit C
means vitamin C.
(TIF)
Figure S3 Signal transduction and cell cycle analyses in
MDS guinea pig at different periods. (Panel A) EGFR was
immunoprecipitated (IP) with anti-EGFR and the precipitated
proteins were immunoblotted (IB) with anti-phospho-Try (PY20)
and anti-EGFR. (Panel B) Immunoblots of HRAS+KRAS,
ERK1/2, p-ERK1/2, c-Myc, p-c-Myc, Akt and p-Akt.; p-EGFR,
phospho-EGFR; p-ERK1/2, phospho-ERK1/2; p-c-Myc, phos-
pho- c-Myc; p-Akt, phospho-Akt. (Panel C) Cell cycle analyses of
bone marrow by flow cytometry: Y-axis, cell counts; X-axis PI
stain. M1 represents G0/1; M2, S; M3, G2/M- phase. Vit C
means vitamin C.
(TIF)
Table S1 Peripheral blood cell count of different treated male
guinea pigs.
(DOC)
Table S2 Myeloid and Nonmyeloid cell ratio in bone marrow.
(DOC)
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